EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 143 filers reported holding EPIZYME INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,465,000 | +37.1% | 16,642,727 | +7.2% | 0.02% | +69.2% |
| Q1 2022 | $17,851,000 | -53.5% | 15,522,777 | +1.0% | 0.01% | -51.9% |
| Q4 2021 | $38,416,000 | -51.0% | 15,366,477 | +0.4% | 0.03% | -50.9% |
| Q3 2021 | $78,389,000 | -38.3% | 15,310,377 | +0.1% | 0.06% | -35.3% |
| Q2 2021 | $127,039,000 | -4.3% | 15,287,477 | +0.3% | 0.08% | -8.6% |
| Q1 2021 | $132,715,000 | -19.6% | 15,237,127 | +0.2% | 0.09% | -24.4% |
| Q4 2020 | $165,165,000 | -8.1% | 15,208,527 | +0.9% | 0.12% | -16.9% |
| Q3 2020 | $179,766,000 | -25.7% | 15,068,427 | +0.1% | 0.15% | -28.5% |
| Q2 2020 | $241,797,000 | +14.9% | 15,055,837 | +11.0% | 0.21% | +0.5% |
| Q1 2020 | $210,387,000 | -37.4% | 13,564,581 | -0.7% | 0.21% | -15.6% |
| Q4 2019 | $336,014,000 | +183.9% | 13,659,104 | +19.0% | 0.24% | +156.8% |
| Q3 2019 | $118,358,000 | -8.0% | 11,474,327 | +11.9% | 0.10% | 0.0% |
| Q2 2019 | $128,715,000 | +1.3% | 10,256,201 | +0.0% | 0.10% | +2.2% |
| Q1 2019 | $127,045,000 | +115.8% | 10,253,801 | +7.3% | 0.09% | +93.8% |
| Q4 2018 | $58,868,000 | -42.6% | 9,556,527 | -1.2% | 0.05% | -30.4% |
| Q3 2018 | $102,491,000 | -21.7% | 9,668,927 | +0.1% | 0.07% | -28.9% |
| Q2 2018 | $130,834,000 | -10.9% | 9,655,627 | +16.7% | 0.10% | -11.8% |
| Q1 2018 | $146,805,000 | +41.4% | 8,270,727 | -0.1% | 0.11% | +37.5% |
| Q4 2017 | $103,855,000 | -34.0% | 8,275,327 | +0.1% | 0.08% | -38.5% |
| Q3 2017 | $157,472,000 | +59.5% | 8,266,227 | +26.4% | 0.13% | +52.9% |
| Q2 2017 | $98,726,000 | -12.0% | 6,538,127 | -0.0% | 0.08% | -16.7% |
| Q1 2017 | $112,184,000 | +41.7% | 6,541,327 | -0.0% | 0.10% | +30.8% |
| Q4 2016 | $79,174,000 | +23.3% | 6,543,327 | +0.3% | 0.08% | +21.9% |
| Q3 2016 | $64,209,000 | -3.8% | 6,525,327 | +0.1% | 0.06% | -9.9% |
| Q2 2016 | $66,727,000 | -15.5% | 6,516,327 | -0.0% | 0.07% | -13.4% |
| Q1 2016 | $79,006,000 | -6.0% | 6,518,627 | +24.3% | 0.08% | -4.7% |
| Q4 2015 | $84,035,000 | +8.2% | 5,245,627 | -13.1% | 0.09% | 0.0% |
| Q3 2015 | $77,664,000 | -46.3% | 6,039,205 | +0.3% | 0.09% | -39.4% |
| Q2 2015 | $144,567,000 | +27.8% | 6,023,605 | 0.0% | 0.14% | +29.1% |
| Q1 2015 | $113,123,000 | +45.7% | 6,023,605 | +46.4% | 0.11% | +39.2% |
| Q4 2014 | $77,631,000 | +101.4% | 4,114,008 | +189.4% | 0.08% | +92.7% |
| Q3 2014 | $38,541,000 | +4.5% | 1,421,662 | +19.9% | 0.04% | +2.5% |
| Q2 2014 | $36,898,000 | +36.9% | 1,185,662 | +0.2% | 0.04% | +29.0% |
| Q1 2014 | $26,954,000 | +438.9% | 1,183,750 | +392.2% | 0.03% | +416.7% |
| Q4 2013 | $5,002,000 | -48.0% | 240,500 | 0.0% | 0.01% | -53.8% |
| Q3 2013 | $9,620,000 | +42.2% | 240,500 | 0.0% | 0.01% | +30.0% |
| Q2 2013 | $6,765,000 | – | 240,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |